GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » EBIT

Medinet Co (TSE:2370) EBIT : 円-1,391.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co EBIT?

Medinet Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was 円-340.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-1,391.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medinet Co's annualized ROC % for the quarter that ended in Mar. 2024 was -122.74%. Medinet Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -252.62%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medinet Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -20.20%.


Medinet Co EBIT Historical Data

The historical data trend for Medinet Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co EBIT Chart

Medinet Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -786.96 -836.03 -837.74 -1,248.69 -1,433.74

Medinet Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -350.00 -367.43 -391.85 -291.97 -340.54

Competitive Comparison of Medinet Co's EBIT

For the Biotechnology subindustry, Medinet Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medinet Co's EV-to-EBIT falls into.



Medinet Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,391.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co  (TSE:2370) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medinet Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-1459.392 * ( 1 - -0.31% )/( (1254.663 + 1130.695)/ 2 )
=-1463.9161152/1192.679
=-122.74 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6348.677 - 60.871 - ( 5033.143 - max(0, 272.895 - 5393.515+5033.143))
=1254.663

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6100.265 - 68.283 - ( 4901.287 - max(0, 256.745 - 5206.551+4901.287))
=1130.695

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medinet Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1362.16/( ( (483.56 + max(87.477000000001, 0)) + (458.886 + max(48.519, 0)) )/ 2 )
=-1362.16/( ( 571.037 + 507.405 )/ 2 )
=-1362.16/539.221
=-252.62 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(225.208 + 48.906 + 86.258000000001) - (60.871 + 0 + 212.024)
=87.477000000001

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(204.451 + 51.896 + 48.917) - (68.283 + 0 + 188.462)
=48.519

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medinet Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-1391.786/6891.545
=-20.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co EBIT Related Terms

Thank you for viewing the detailed overview of Medinet Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co (TSE:2370) Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co (TSE:2370) Headlines

No Headlines